A method for detecting GP73 based on MoS2-Fc@PANi nanocomposites for non-diagnostic purposes
By combining MoS2-Fc@PANi nanocomposites with GP73 aptamer, combining gold nanoparticles to modify electrodes, sandwich electrochemical aptamer sensor is solved, and the existing GP73 detection methods have low sensitivity and complex operation are solved. High sensitivity and low cost GP73 detection is achieved.
Patent Information
- Application Number
- CN202211470646.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-11-23
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2042-11-23
AI Technical Summary
The existing GP73 detection methods have problems such as low sensitivity, complex operation and high cost, making it difficult to achieve fast, sensitive and simple operation detection.
Sandwich aptamer sensor is constructed based on molybdenum disulfide-ferrocene@polyaniline (MoS2-Fc@PANi) nanocomposite, and bound to GP73 aptamer through amide bond and π-π bond adsorption, and gold nanometers are bound to Particle-modified screen-printed electrodes are used to achieve specific detection of GP73 using electrochemical methods.
GP73 detection with a minimum detection limit of 0.001ng/mL is realized, which improves detection sensitivity and operation simplicity and reduces detection costs.
Smart Images

Figure CN115753915B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biological detection, and specifically relates to a method for detecting GP73 by constructing a sandwich aptamer sensor based on a nanocomposite material. Background Art
[0002] Primary hepatocellular carcinoma (HCC) is one of the top five cancers in the world and poses a huge threat to life and health. Golgi protein 73 (GP73) is a new liver cancer marker, and the main detection methods include radioimmunoassay, fluorescent immunoassay, electrochemical immunosensor, piezoelectric immunosensor, etc. The invention patent with publication number CN 111413502 A relates to a method for detecting GP73 serum using a commercial ELISA kit; the invention patent with publication number CN 113945713 A relates to a method for detecting tumor markers such as GP73 using a new biochip, which meets the needs of large-scale sample testing. However, the prior art still has the disadvantages of low detection sensitivity of GP73, complex operation, and high cost. Therefore, a rapid, sensitive, and easy-to-operate GP73 detection method is needed. Summary of the invention
[0003] The technical problem to be solved by the present invention is to provide a molybdenum disulfide-ferrocene@polyaniline (MoS 2 -Fc@PANi) nanocomposite materials were used to construct sandwich aptamer sensors to detect GP73 with a minimum detection limit of 0.001 ng / mL.
[0004] In order to solve this technical problem, a nanocomposite material with high specific surface area and high conductivity was successfully synthesized by utilizing the adsorption effect of amide bonds and π-π bonds, and the nanocomposite material was bonded to the GP73 aptamer (GP73 Apt ) to form MoS that can specifically bind to GP73 2 -Fc@PANi-GP73 Apt signal probe; gold nanoparticles (Au NPs) were modified on the surface of screen-printed electrodes (SPE) by electrodeposition technology; GP73 Apt Loaded on the electrode surface of modified AuNPs, the aptamer forms an unstable spatial structure in the form of a single chain and exists on the electrode surface; GP73 and MoS 2 -Fc@PANi-GP73 Apt The signal probe was incubated on the electrode surface. Since GP73 could specifically bind to the GP73 aptamer, a stable spatial structure was formed and orderly arranged on the electrode surface to construct the MoS 2 -Fc@PANi-GP73 Apt / GP73 / GP73 Apt / AuNPs / SPE sandwich electrochemical aptasensor. MoS 2 -Fc@PANi is used to detect the redox peak current change value of Fc, thereby realizing the detection of GP73.
[0005] The present invention is carried out according to the following steps:
[0006] Step 1: MoS 2 -Fc@PANi-GP73 Apt Preparation of signal probe
[0007] (1) Preparation of ferrocene@polyaniline (Fc@PANi): Fc and PANi were added to acetic acid (CH 3 COOH) solution, then add 1-ethyl-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS), stir, centrifuge, and wash to obtain Fc@PANi solid;
[0008] As an improvement, the following steps are also included:
[0009] (2) MoS2-ferrocene@polyaniline (MoS 2 -Fc@PANi) preparation: Molybdenum disulfide (MoS 2 ) was added with water and ultrasonically crushed to prepare MoS 2 The suspension was then added with Fc@PANi, stirred, centrifuged, and washed to obtain MoS 2 -Fc@PANi solution;
[0010] (3) MoS2-ferrocene@polyaniline-GP73 aptamer (MoS 2 -Fc@PANi-GP73 Apt ) signal probe preparation: GP73 aptamer (GP73 Apt ) solution and MoS 2 -Fc@PANi solution was uniformly mixed by ultrasonication, incubated, centrifuged and washed to obtain MoS 2 -Fc@PANi-GP73 Apt Signal probe.
[0011] Step 2: Electrode modification and biosensing interface construction
[0012] (1) Place the screen-printed electrode (SPE) in dilute sulfuric acid (H 2 SO 4 ) solution;
[0013] (2) The activated SPE was placed in a solution containing chloroauric acid (HAuCl 4) solution, and then electrodeposited to obtain AuNPs / SPE electrode;
[0014] (3) GP73 Apt Drop it on the surface of AuNPs / SPE, incubate, wash and blow dry to obtain GP73 Apt / Au NPs / SPE;
[0015] Step 3: Drawing of GP73 working curve
[0016] (1) Add different concentrations of GP73 standard solution to the electrochemical biosensor interface obtained in step 2, incubate, wash, and blow dry to obtain GP73 / GP73 Apt / AuNPs / SPE;
[0017] (2) In GP73 / GP73 Apt MoS / Au NPs / SPE 2 -Fc@PANi-GP73 Apt Solution, incubation, washing, and drying to obtain MoS 2 -Fc@PANi-GP73 Apt / GP73 / GP73 Apt / Au NPs / SPE. The working electrode was then immersed in a phosphate buffered saline (PBS) solution, and the DPV scanning of the electrochemical workstation was used to record the response current of the sensor.
[0018] (3) Detect different concentrations of GP73 and record the peak current; draw a working curve of GP73 based on the relationship between the current response value of the sensor and the GP73 concentration, and calculate the minimum detection limit of the method.
[0019] Step 4: Detection of GP73 in actual serum samples
[0020] (1) GP73 obtained in step 2 Apt / Au NPs / SPE sensing interface, add the actual sample to be tested, and then add MoS 2 -Fc@PANi-GP73 Apt The signal probe was incubated, washed and dried to obtain a working electrode. The successfully prepared working electrode was immersed in a PBS solution, and the DPV scanning of the electrochemical workstation was used to record the response current value of the sensor.
[0021] (2) According to the working curve obtained in step 3, the concentration of GP73 in the actual sample to be tested is calculated.
[0022] As a preference:
[0023] Step 1 GP73 AptThe DNA sequence is 5′-NH 2 -C 6 -GCAGTTGATCCTTTGGATACCCTGG-3′;
[0024] HAuCl used to deposit gold as described in step 2 4 The solution concentration is 0.1%;
[0025] In step 3 and step 4, the incubation temperature of the electrode is 25° C., the incubation time is 40 min, the pH value of the PBS buffer is 7.0, and when the concentration of the signal probe is 0.5 mg / mL, the response current of the sensor is the largest, and the current value can reach 15.7 μA.
[0026] Among them, step 1 provides a MoS with large specific surface area, high conductivity and high electrochemical activity. 2 -Fc@PANi nanocomposites, with GP73 Apt MoS is formed by π-π bonding 2 -Fc@PANi-GP73 Apt The nanosignal probe provides a detection signal for step 2; step 2 constitutes a biosensing interface that specifically recognizes GP73, and combined with the signal probe, it constitutes an aptamer-protein-aptamer sandwich biosensor with a stable chemical structure. The construction of the biosensing interface in step 2 is an essential key step in the electrochemical detection of GP73 in steps 3 and 4; the working curve of GP73 in step 3 provides a calculation basis for the determination of GP73 concentration in the actual sample in step 4. It can be seen that steps 1-4 support each other and work together, so MoS 2 -Fc@PANi、GP73 Apt , and Au NPs deposition to realize the detection of GP73 by sandwich-type electrochemical aptamer sensor.
[0027] Compared with the prior art, the present invention has the following advantages:
[0028] (1) This method first prepared MoS with unique morphology 2 -Fc@PANi nanocomposites; Enhanced electron transfer using PANi and MoS 2 The effective amplification of current signals and excellent loading capacity, combined with the high affinity of GP73 aptamers, successfully prepared MoS 2 -Fc@PANi-GP73 Apt Signal probe, which can specifically recognize GP73 protein;
[0029] (2) The use of AuNPs nanomaterials to modify the electrode surface can not only effectively fix the GP73 aptamer, but also enhance the transfer efficiency between electrons due to its excellent conductive properties, effectively amplifying the detected current signal;
[0030] (3) MoS 2 -Fc@PANi nanocomposites are used as electroactive materials to construct MoS 2 -Fc@PANi aptamer-protein-aptamer sandwich electrochemical aptamer sensor is used to detect GP73. The sandwich structure is more stable and has higher precision, which is conducive to the detection of targeted molecules. The minimum detection limit of this method is 0.001ng / mL. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 Based on MoS 2 -Schematic diagram of the construction of sandwich-type electrochemical aptasensor for detecting GP73 using Fc@PANi nanocomposite materials;
[0032] Figure 2 MoS 2 - Transmission electron microscopy (TEM) image of Fc@PANi nanocomposite;
[0033] Figure 3 Scanning electron microscopy (SEM) characterization images of different modification processes on the electrode surface;
[0034] Figure 4 DPV profiles of different GP73 concentrations. DETAILED DESCRIPTION
[0035] The present invention is described in detail below with reference to the accompanying drawings and specific embodiments.
[0036] A MoS-based 2 The principle of constructing sandwich-type electrochemical aptasensor based on Fc@PANi nanocomposite to detect GP73 is shown in Figure 1 First, Au NPs were modified on the surface of activated screen-printed electrodes by electrodeposition technology, and the GP73 aptamer (GP73 Apt ) was loaded on the Au NPs / SPE surface to form a biosensing interface; then the prepared MoS 2 -Fc@PANi nanocomposite combined with GP73 Apt Formation of MoS 2 -Fc@PANi-GP73 Apt Signal probe, GP73 is added to the biosensor interface and incubated, then the signal probe is added, GP73 AptIt will specifically bind to GP73 protein to form an aptamer-protein-aptamer sandwich complex and arrange in an orderly manner on the surface of space in a stable spatial structure. 2 -Fc@PANi vs GP73 Apt The high loading capacity and good electron transfer effect of Au NPs, as well as the high conductivity of GP73 Apt The specific recognition of GP73 was recorded by differential pulse voltammetry (DPV) on an electrochemical workstation. 2 - Change in the redox peak current of Fc in Fc@PANi. Draw a curve between the current value of the sensor and the concentration of GP73 to achieve quantitative detection of GP73. The implementation steps are as follows:
[0037] 1. MoS 2 -Fc@PANi-GP73 Apt Preparation of signal probe:
[0038] Weigh 100.0 mg of PANi and 100.0 mg of Fc and disperse them in 50.0 mL of pure water, add 0.5 mL of acetic acid solution, stir evenly, then add 19.0 mg of EDC and 5.3 mg of NHS catalyst, stir for 24 h, centrifuge and wash to obtain Fc@PANi solid. Weigh 20.0 mg of MoS 2 Dispersed in 20.0 mL pure water and crushed for 1 h, 20.0 mg of Fc@PANi solid was added to MoS 2 The suspension was stirred for 48 hours, centrifuged and washed to obtain MoS 2 -Fc@PANi solution. 20.0 μL of 100.0 μM GP73 Apt and 100.0 μL of 2.0 mg / mL MoS 2 -Fc@PANi solution, incubated at 4 °C for 12 h, centrifuged and washed to obtain MoS 2 -Fc@PANi-GP73 Apt Signal probe. The nanocomposites were characterized using a JEM-1200EX transmission electron microscope (TEM). Figure 2 shown. Figure 2 A is the TEM image of PNAi, showing a strip-like nanofiber structure; Figure 2 B is the TEM image of Fc@PANi, showing the Fc attached to the surface; Figure 2 C is MoS 2 -TEM image of Fc@PANi, showing a flake-like structure, proving that Fc@PANi has been successfully attached to MoS 2 surface, indicating that MoS 2 -Fc@PANi nanocomposite material was successfully constructed.
[0039] 2. Electrode modification and construction of biosensing interface: The screen-printed electrode (SPE) was immersed in dilute H 2 SO 4 The pretreated electrode was placed in 1.0 mL of 0.1% HAuCl 4 In the solution, the it technology in the electrochemical workstation was used to deposit for 120s at a scanning voltage of 0-1.2V, and then washed and dried to obtain AuNPs / SPE. 2.0μL of 5.0μM GP73 Apt Add it to the surface of Au NPs / SPE electrode, incubate it at 25℃ for 30min, wash it and blow it dry; add 2.0μL of 1% bovine serum albumin (BSA) solution to the electrode to block the active site, incubate it at 25℃ for 30min, wash it and blow it dry to obtain GP73 Apt / Au NPs / SPE sensing interface.
[0040] 3. Drawing of GP73 working curve: GP73 constructed in step 2 Apt GP73 standard solution with a concentration range of 0.001 ng / mL to 100.0 ng / mL was added to the / Au NPs / SPE sensing interface and incubated at 25 °C for 1 h to obtain GP73 / GP73 Apt / Au NPs / SPE. In GP73 / GP73 Apt 2.0 μL of 0.5 mg / mL MoS was added to the Au NPs / SPE. 2 -Fc@PANi-GP73 Apt The solution was incubated at 25 °C for 1 h, washed and dried to obtain MoS 2 -Fc@PANi-GP73 Apt / GP73 / GP73 Apt / Au NPs / SPE working electrode. The working electrode obtained above was placed in PBS solution (0.2M, pH=7.0), and the DPV scanning of CHI660E electrochemical workstation was used to record its peak current. The DPV curves of different GP73 concentrations are shown in Figure 4 As shown. When the concentration of GP73 is in the range of 0.001ng / mL to 100.0ng / mL, there is a logarithmic linear relationship between the sensor current response value (Y) and the GP73 concentration (X). The working curve is Y=12.2586+4.0761*lgX, and the correlation coefficient is 0.9902. According to formula C LOD =3S d / b(S dThe minimum detection limit was calculated to be 0.001 ng / mL. The electrode construction process was characterized by scanning electron microscopy (SEM). Figure 3 shown. Figure 3 A is the SEM image of SPE, and the electrode surface appears rough and gray due to its inherent carbon particles; Figure 3 B is the SEM image of Au NPs / SPE, where many bright spherical particles are evenly distributed on the electrode surface, indicating that Au NPs are successfully deposited on the electrode surface; Figure 3 C is GP73 Apt The SEM image of Au NPs / SPE shows that the surface is covered with a thin film, indicating that GP73 Apt Successfully fixed on the electrode surface. Figure 3 In D, the film surface is relatively smooth, which is attributed to the interaction between GP73 and GP73. Apt The reactions formed a stable structure, indicating that GP73 was successfully adsorbed on the electrode surface. Figure 3 E is MoS 2 -Fc@PANi-GP73 Apt / GP73 / GP73 Apt / AuNPs / SPE, the surface shows a typical wrinkled structure and is wrapped with many flaky nanoparticles, proving that MoS 2 -Fc@PANi-GP73 Apt It has been evenly modified on the electrode surface.
[0041] 4. Detection of GP73 in actual serum samples: The GP73 level in human serum samples was detected by direct measurement. The three types of serum samples with known GP73 concentrations (normal serum sample 1, liver cancer serum sample 2, and liver cancer serum sample 3) were diluted 10 times, and 2.0 μL of serum solution was added to the GP73 electrochemical biosensor interface constructed in step 2 and incubated at 25°C for 30 min. Then 2.0 μL of 0.5 mg / mL MoS 2 -Fc@PANi-GP73 Apt The solution was incubated at 25 °C for 1 h, washed and dried to obtain MoS 2 -Fc@PANi-GP73 Apt / GP73 / GP73 Apt / AuNPs / SPE working electrode. As described in step 3, the working electrode was placed in a PBS solution (0.2M, pH=7.0) for DPV scanning and the current value was recorded. The collection and processing of serum samples this time have met the requirements of the ethics committee of the Guangxi Key Laboratory of Metabolic Disease Research, and the concentration of GP73 in clinical serum was obtained by ELISA. The concentration of GP73 in each serum sample was calculated using the GP73 working curve obtained in step 3. The results are shown in Table 1. The relative error of the aptamer sensor is in the range of 0.05%-7.3%. The results show that the electrochemical aptamer sensor can be used to detect the concentration of GP73 in actual serum samples.
[0042] Table 1 Detection results of GP73 in actual serum samples
[0043]
Claims
1. A non-diagnostic method based on molybdenum disulfide-ferrocene@polyaniline MoS 2 The method for detecting GP73 in Fc@PANi nanocomposites is carried out in the following steps: Step 1: MoS2-ferrocene@polyaniline-GP73 aptamer MoS 2 -Fc@PANi-GP73 Apt Preparation of signal probe (1) Preparation of ferrocene@polyaniline Fc@PANi: Ferrocene Fc and polyaniline PANi were added to acetic acid CH 3 Add 1-ethyl-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) to the COOH solution, stir, centrifuge, and wash to obtain Fc@PANi solid; (2) MoS2-ferrocene@polyaniline MoS 2 Preparation of -Fc@PANi: MoS 2 Pour into pure water and crush, add Fc@PANi solid, stir, centrifuge, wash, and obtain MoS 2 -Fc@PANi solution; (3) MoS 2 -Fc@PANi-GP73 Apt Preparation of signal probe: GP73 aptamer GP73 Apt Solution and MoS 2 -Fc@PANi solution was uniformly mixed, incubated, centrifuged, and washed to obtain MoS 2 -Fc@PANi-GP73 Apt Signal probe; Step 2: Electrode modification and biosensing interface construction (1) Place the screen-printed electrode SPE in dilute H 2 SO 4 Activation in solution; (2) The activated SPE was placed in a HAuCl 4 The Au NPs / SPE was obtained by electrodeposition in a solution of ; (3) GP73 Apt Add dropwise onto the AuNPs / SPE surface, incubate, wash, and blow dry to obtain GP73 Apt / Au NPs / SPE; Step 3: Drawing of GP73 working curve (1) Add GP73 standard solution to GP73 Apt / AuNPs / SPE surface, incubation, washing, and drying to obtain GP73 / GP73 Apt / AuNPs / SPE; (2) In GP73 / GP73 Apt MoS / Au NPs / SPE 2 -Fc@PANi-GP73 Apt Solution, incubation, washing, and drying to obtain the electrode MoS 2 -Fc@PANi-GP73 Apt / GP73 / GP73 Apt / Au NPs / SPE; (3) The working electrode was immersed in phosphate buffer solution (PBS), and the DPV scanning of the electrochemical workstation was used to record the response current of the sensor; (4) Detecting different concentrations of GP73 respectively and recording the peak current; drawing the working curve of GP73 based on the relationship between the current response value of the sensor and the GP73 concentration, and calculating the minimum detection limit of the method; Step 4: Detection of GP73 in actual serum samples (1) The working electrode prepared with the actual serum sample was immersed in the PBS solution, and the DPV of the electrochemical workstation was used for scanning to record the response current value of the sensor; (2) According to the working curve obtained in step 3, the concentration of GP73 in the actual serum sample is calculated.
2. The method according to claim 1, Features: MoS as described in step 1 2 -Fc@PANi nanocomposite concentration was 1.0 mg / mL.
3. The method according to claim 1, Features: MoS as described in step 1 2 -Fc@PANi-GP73 Apt The signal probe concentration was 0.5 mg / mL.
4. The method according to claim 1, Features: GP73 as described in steps 1 and 2 Apt The DNA sequence was 5′-GCAGTTGATCCTTTGGATACCCTGG-3′ and the concentration was 5.0 μM.
5. The method according to claim 1, Features: The concentration of the PBS solution in step 3 and step 4 is 0.2 M, and the pH value is 7.0.
Citation Information
Patent Citations
New application of GP73 and liver tissue inflammatory activity detection kit based on GP73
CN111413502A
Biochip for combined detection of multiple tumor markers and preparation and application thereof
CN113945713A
Semiconductor electrochemical sensors
CN101765766A
Preparation and application of probe for detecting liver cancer marker GP73
CN109254152A
Method for detecting GPC3 based on H-rGO-Pd NPs and Au NPs (at) rGO nanometer materials
CN114252489A
